Glimepiride structure
Glimepiride
Glimepiride(Amaryl) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.Target: DPP4Glimepiride (Hoe 490) is a new sulfonylurea. After oral administration of Hoe 490 to rabbits, blood glucose was lowered 3.5 times more than after glibenclamide (HB 419) and after intravenous administration, 2.5 times more [1]. glimepiride decreased extracellular Aβ40 and Aβ42 levels. glimepiride may serve as a promising drug for the treatment of AD associated with diab
Find 46 Related Holders
Oman Chemicals And Pharmaceuticals L.L.C.
European Union
European Union
API Registration Country
API Inactive
KORES (INDIA) LIMITED
European Union
European Union
API Registration Country
API Inactive
SHENZHEN HAORUI INDUSTRIAL DEV. CO., LTD.
European Union
European Union
API Registration Country
API Inactive
ZENTIVA K.S. Praha
European Union
European Union
API Registration Country
API Inactive
HUBEI HAOSUN PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
Sun Pharmaceutical Industries Ltd
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Glimepiride
-
CN1 YR
Contact Supplier -
Hangzhou KieRay Chem Co.,LTD
CN1 YR
Contact Supplier -
bazayan Enterprises LLP
IN1 YR
Contact Supplier -
Shaanxi TNJONE Pharmaceutical Co., Ltd
CN1 YR
Contact Supplier -
Xi'an Horlden Bio-Tech Co., Ltd
CN1 YR
Contact Supplier